HomeGPT expands the Company’s vertical AI strategy with multimodal home design, renovation visualization and AI-powered residential decision tools
Exhibition “Dunhuang – A Great Cultural Treasure” Opens at Hunan Museum
Changsha, China, July 21, 2026 (GLOBE NEWSWIRE) — On the morning of June 30, the grand special exhibition “Dunhuang – A Great Cultural Treasure” officially opened at the Hunan Museum. Zhang Xiaogang, Deputy Director of the Dunhuang Academy, Li Lihui, Deputy Curator of the Hunan Museum, and Su Xing, Deputy Curator of the Dunhuang Museum, attended the opening ceremony and delivered speeches. Representatives of cultural and museum institutions from inside and outside Hunan, the curatorial team, and journalists from major mainstream media witnessed the launch of the exhibition together.
Abundia Global Impact Group Expands Leadership Team with the Appointment of Keith Berger as Chief Commercial Officer
Veteran energy and technology executive to lead Abundia’s commercialization strategy, bringing a successful record of scaling operations and executing commercial and industrial infrastructure projects
Rocket Doctor Joins National Coalition Advocating for Permanent Medicare Telehealth
Vancouver, BC, July 21, 2026 (GLOBE NEWSWIRE) — Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor AI” or the “Company”) today announced that its wholly owned digital health platform and marketplace subsidiary, Rocket Doctor Inc., has joined the Alliance for Connected Care’s Telehealth Voters Pledge, a growing national coalition advocating for permanent Medicare telehealth legislation in the United States.
CISO Global Advances AI Software-Led Cybersecurity Strategy with FedRAMP-Certified TiGRIS GRC Platform
TiGRIS expands CISO Global’s software portfolio with compliance automation built on deep cyber, audit, and risk management expertise.
Logistics Division Hyper-Growth (+80% CAGR) Unlocks Multi-Year Run Rate — Accelerating CLIK’s High-Margin Care U Expansion & Strategic Spin-Off
Hong Kong, July 21, 2026 (GLOBE NEWSWIRE) — Click Holdings Limited (“Click Holdings” or “Click” or “we” or “us”, NASDAQ: CLIK) and its subsidiaries (collectively, the “Company”), a leader in human resources (“HR”) and senior care solutions in Hong Kong, today announced that its high-flying logistics division continues to break records, orchestrating an explosive, high-margin trajectory from a modest FY2024 baseline to record monthly revenue exceeding HK$4.37 million by June 2026. This represents an extraordinary compound annual growth rate (CAGR) exceeding 80% across FY2024–2026, solidifying the business as a self-sustaining, hyper-scalable growth engine powering the broader Group.
Monaco Associates’ Book Launch Practice Acquired by Caraballo & Co.
Veterinary Services Market Size to Reach USD 247.32 Billion by 2035 | SNS Insider
The U.S. Veterinary Services Market is projected to grow from USD 52.80 Billion in 2025 to USD 104.84 Billion by 2035, while Europe is expected to expand from USD 33.74 Billion to USD 67.58 Billion, supported by rising companion animal healthcare spending, veterinary diagnostics, and pet insurance adoption.
Novo Nordisk takes action to stop multiple misleading national GLP-1 advertising campaigns by Eli Lilly
ParaZero Receives Follow-On Order for Operational System Protecting High-Value Assets and Critical Infrastructure
DefendAir Pods will support an autonomous Counter-UAS application within an operational protection system
PolyPid Announces Exclusive Partnership with Azurity Pharmaceuticals for the Commercialization of D-PLEX₁₀₀ in the U.S. and Canada
PETACH TIKVA, Israel, July 21, 2026 (GLOBE NEWSWIRE) — PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), an innovative biopharmaceutical company dedicated to elevating treatment effectiveness, right where care begins, today announced that it has entered into an exclusive commercial partnership agreement (the “Agreement”) with Azurity Pharmaceuticals (“Azurity”), a privately held specialty pharmaceutical company, for the commercialization of D-PLEX100 in the United States and Canada for the prevention of surgical site infections (“SSIs”).
NIOB Seigneurie Assays Confirm Niobium Mineralization in hole seven
Hole’s final assays return 842.3 ppm and 453 ppm niobium oxide over 10 and 7.3 metres plus 2,701.7 ppm copper over 3 metres
FreightCar America, Inc. Continues Aftermarket Expansion with Acquisition of Leading Regional Distributor
Jupiter Neurosciences (NASDAQ: JUNS) Signs Definitive Agreement for Exclusive U.S. Rights to ALA-002 in Transaction Valued at Up to $100 Million
Transaction expands Jupiter into a dual clinical-stage CNS company by adding a differentiated FDA-designated Novel Chemical Entity alongside its Phase II Parkinson’s disease program
CEO Letter – Beamr’s Path Forward – Solving the Visual Data Challenge for Autonomous Vehicles
Herzliya, Israel, July 21, 2026 (GLOBE NEWSWIRE) — Beamr Imaging Ltd. (NASDAQ: BMR), a leader in video optimization technology and solutions, today issued a Letter to Shareholders from Sharon Carmel, Chief Executive Officer.
Tecnoglass Sets Date for Second Quarter 2026 Results
Miami, FL, July 21, 2026 (GLOBE NEWSWIRE) — Tecnoglass, Inc. (NYSE: TGLS) (“Tecnoglass” or the “Company”), a leading producer of high-end aluminum and vinyl windows and architectural glass for the global residential and commercial end markets, today announced it will release financial results for the second quarter 2026 before the market opens on Thursday, August 6, 2026. Management will host a webcast and conference call that same day at 10:00 a.m. Eastern time to review the Company’s results.
BioNTech to Report Second Quarter 2026 Financial Results and Corporate Update on August 4, 2026
MAINZ, Germany, July 21, 2026 (GLOBE NEWSWIRE) – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will announce its financial results for the second quarter 2026 on Tuesday, August 4, 2026. Additionally, the Company will host a conference call and webcast that day at 8:00 a.m. ET (2:00 p.m. CET) for investors, financial analysts and the general public to discuss its financial results and provide a corporate update.
BioNTech veröffentlicht am 4. August 2026 Ergebnisse für das zweite Quartal 2026 und informiert über operativen Fortschritt
MAINZ, Deutschland, 21. Juli 2026 (GLOBE NEWSWIRE) — BioNTech SE (Nasdaq: BNTX, „BioNTech“ oder „das Unternehmen“) wird am Dienstag, den 4. August 2026, die Ergebnisse für das zweite Quartal 2026 veröffentlichen. Darüber hinaus wird das Unternehmen am selben Tag um 14:00 Uhr MEZ (8:00 Uhr Eastern Time) eine Telefonkonferenz samt Webcast für Investoren, Finanzanalysten sowie die allgemeine Öffentlichkeit durchführen, um die Finanzergebnisse sowie ein Unternehmensupdate zu präsentieren.